MLTX trade ideas
(NASDAQ:MLTX) MoonLake Immunotherapeutics Earnings Beat By $0.05Fundamentals
MoonLake Immunotherapeutics (NASDAQ: MLTX) reported third quarter EPS of $-0.18, $0.05 better than the analyst estimate of $-0.23. Revenue for the quarter came in at $0 versus the consensus estimate of $0.
MoonLake Immunotherapeutics's stock price closed at $37.40. It is down -35.10% in the last 3 months and up 317.77% in the last 12 months.
Technical Analysist
MoonLake Immunotherapeutics has a market capitalization of $2.16 billion. MLTX is trading in the middle of its 52-week range and above its 200-day simple moving average.
What does this mean?
Investors are still evaluating the share price, but the stock still appears to have some upward momentum. This is a positive sign for the stock's future value.
#MLTX Straddle with high volume. Reaction on levels Very High probability of reaction on reversal levels.
Based on our team's research of the options market, we expect buy activity at the support level or sell activity at the resistance.
We primarily consider levels to be activity zones, but not to be a super-fine level for establishing a limit order. Use them in combination with your own strategy.
MLTX Going ATH Price is testing to break ath.
Indicator
MACD showing positive sign
RSI is moving upward
Volume break previous average
Moving Average maintain upside as MA50 still intact trendly
All confluences showing positive sign.
Trading Plan:
Buying on breakout at range EMA 5 and 9 or at MA20
If price maintain upward at EMA9, hold for long
Cut loss if price break in range MA50 and EMA90 (Risk Taking)
or
Cut loss at risk average 5-10%